Skip to main content
. 2022 Mar 14;13:858947. doi: 10.3389/fphar.2022.858947

TABLE 1.

Overview of the studies presenting measures of non-adherences among Jamaicans living with NCDs. For all studies the measure of adherence.

References Chronic disorder of patients (sample size) Non-adherence rate (based on self-report) Theme identified by patients as reasons for non-adherence
Adeniyi et al. (2021) DM and HTN (85) 40% for patients with only DM Financial difficulty, Insurance problems, medication non-availability at local pharmacy and difficulty collecting medication
31.2% for patients with only HTN
30.8% for both conditions
Barrett-Brown et al. (2021) DM (101) 53.5% High pill burden—“tired of taking medications”
Bridgelal-Nagassar et al. (2016) DM (260) 33% overall; 28.5% amongst those with health-insurance Not reported
Chambers et al. (2008) Systemic lupus erythematosus (75) 44% Financial difficulty, medication non-availability in local pharmacy, fear of side effects, preference for herbal therapies, perception of mild disease, religious beliefs
Duff et al. (2006) DM (133) 55% Not reported
Gossell-Williams et al. (2014) 52 HTN (52) Range from 9.6 to 40.4% Adverse drug reactions, prefer not to take medication in the absence of symptoms, general inconvenience and pill burden
Mowatt (2013) DM (104) 34% Not specified
Pusey-Murray et al. (2010) Mental disorders (344) 55.3% Side-effects, running out of medication, forgetting to take medication, medication makes things worse
Watson and Ferrillo, (2021) DM and HTN (116) 19.2% for patients with DM Did not recognize the importance of taking medication consistently to manage chronic illness
32.1% for patients with HTN
Welsh et al. (2015) HTN (48) 56.3% Adverse drug reactions, pill burden, difficulty obtaining medication at the pharmacy, preference for herbal therapies
Wilson et al. (2018) HTN (307) 17.5% for patients with uncontrolled HTN Not reported
21.4% for patients with controlled HTN

DM, diabetes mellitus; HTN, hypertension.